Cambridge Capital Group members’ 100th deal completed

We salute our members, who have now made the 100th investment as Cambridge Capital Group since inception.

Formed in October 2000 by entrepreneurs, founding members of Cambridge Capital group began investing in spin-outs from the Cambridge hi-tech cluster in early 2001. This quarter, in our 17th year of angel investing, we have participated in the funding of these exciting early-stage ventures:

Ablatus – novel tissue ablation to treat solid tumours

Sensize – SaaS system to track and monitor shipments at a fraction of the cost of legacy methods

Sentisum – real-time customer experience intelligence for enterprises

Rootwave – chemical-free weedkilling by electricides for gardening, horticulture and agriculture.

In recent months we have also supported follow-on rounds in Lightpoint Medical, Osprey Engines, Featurespace, Viewranger and SupaPass. Three other new deals are also in process (in virtual reality, cyber security and contract drug discovery).

In the early years of our portfolio development it was about hardware or software, but these days our members invest in a wide range of sectors, many of which had not been invented when we started. This year alone we have invested in agritech, medtech, engineering, biotech, robotics, machine learning, IoT (internet of Things), even legaltech and fashiontech!

The group has invested more than £25m into 100+ start-ups, mainly in the Cambridge cluster, still Europe’s most important B2B centre. Some companies have received £10k from a single member, others have received £1m-2m from a group syndicate. While some of our portfolio companies have failed due to the high risk nature of investing in start-ups, twelve of our portfolio companies have “exited” profitably over the years, via AIM listings or trade sales, with returns ranging from 2-15X – including four in 2016. The most notable was the $250m sale of the Swiftkey business to Microsoft.

Members of Cambridge Capital Group are private investors and family investment funds drawn from the Cambridge region, London and the Thames Valley as well as international territories such as the Channel Islands and Singapore. They boast a diverse range of sector backgrounds enabling collaboration between group members who co-invest in opportunities that interest them individually.

We therefore salute our brave 80+ members who boldly go where no angel group has gone before, supporting the next generation of hi-technology entrepreneurs in the so called Golden Triangle of Cambridge/London/Oxford – to create sustainable wealth and employment for Great Britain!

For further information see www.cambridgecapitalgroup.co.uk

Investors wanting to join our private network may contact the Directors at


Cambridge Capital Group members’ 100th deal completed

By Cambridge Capital Group01 Nov 2017